Production (Stage)
Century Therapeutics, Inc.
IPSC
$0.583
$0.00761.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 165.12M | 189.29M | 198.11M | 196.40M | 192.02M |
| Total Receivables | 983.00K | 1.52M | 1.35M | 1.76M | 1.58M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.53M | 1.53M | 6.55M | 5.32M | 6.21M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 1.71M | -- | -- | -- |
| Total Current Assets | 169.63M | 194.05M | 206.01M | 203.48M | 199.81M |
|
|
|||||
| Total Current Assets | 169.63M | 194.05M | 206.01M | 203.48M | 199.81M |
| Net Property, Plant & Equipment | 87.76M | 90.85M | 94.11M | 97.98M | 88.32M |
| Long-term Investments | -- | -- | 4.73M | 5.09M | -- |
| Goodwill | -- | -- | 4.73M | 5.09M | -- |
| Total Other Intangibles | 34.20M | 34.20M | 33.80M | 33.30M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.30M | 3.30M | 3.40M | 3.38M | 2.52M |
| Total Assets | 315.61M | 353.22M | 388.62M | 416.45M | 348.51M |
|
|
|||||
| Total Accounts Payable | 3.57M | 3.08M | 2.60M | 3.36M | 3.43M |
| Total Accrued Expenses | 6.05M | 12.59M | 9.69M | 7.43M | 5.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.88M | 4.87M | 3.76M | 3.66M | 2.22M |
| Total Finance Division Other Current Liabilities | -- | 109.25M | 3.78M | 4.71M | 5.10M |
| Total Other Current Liabilities | -- | 109.25M | 3.78M | 4.71M | 5.10M |
| Total Current Liabilities | 14.50M | 129.78M | 19.82M | 19.16M | 16.07M |
|
|
|||||
| Total Current Liabilities | 14.50M | 129.78M | 19.82M | 19.16M | 16.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 47.79M | 48.96M | 50.84M | 52.71M | 44.25M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.87M | 13.11M | 122.27M | 122.47M | 110.31M |
| Total Liabilities | 75.17M | 191.85M | 192.93M | 194.34M | 170.62M |
|
|
|||||
| Common Stock & APIC | 945.91M | 943.38M | 941.19M | 937.45M | 861.96M |
| Retained Earnings | -705.78M | -782.34M | -746.27M | -715.04M | -683.83M |
| Treasury Stock & Other | 305.00K | 324.00K | 758.00K | -309.00K | -241.00K |
| Total Common Equity | 240.44M | 161.36M | 195.69M | 222.10M | 177.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 240.44M | 161.36M | 195.69M | 222.10M | 177.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 240.44M | 161.36M | 195.69M | 222.10M | 177.88M |
|
|
|||||